Japan OKs Phase III Trial Of DMD Drug Tested In Phase I/II Abroad
This article was originally published in PharmAsia News
Executive Summary
Japanese authorities approved Phase III trials for an international study of a drug intended to treat Duchenne muscular dystrophy